Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.

Abstract

Anti-TNF-alpha [anti-(tumour necrosis factor-alpha)] therapy is widely considered to be among the most efficient treatments available for rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. In the present study a tetravalent mini-antibody, named 'TNF-TeAb', was constructed by fusing the tetramerization domain of human p53 to the C… (More)

Topics

  • Presentations referencing similar topics